Evidence map›Paper›PMID 22968430›Full record

ArticleEpigenetics2012

miRNA-218 contributes to the regulation of D-glucuronyl C5-epimerase expression in normal and tumor breast tissues.

Tatiana Y Prudnikova, Luydmila A Mostovich, Vladimir I Kashuba, Ingemar Ernberg, Eugene R Zabarovsky, Elvira V Grigorieva

Open access · hybridAbstract read
In one paragraph

Article in Epigenetics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Prognostic value ofHeliyon · 2023
    Article
  4. Article
  5. Review
  6. Glycosaminoglycanomics: where we are.Glycoconjugate journal · 2017
    Review
  7. Article
  8. Article
  9. D-glucuronyl C5-epimerase cell type specifically affects angiogenesis pathway in different prostate cancer cells.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 6 countries.

Tatiana Y PrudnikovaInstitute of Molecular Biology and Biophysics, Siberian Department of Russian Academy of Medical Sciences, Novosibirsk, Russia.
Luydmila A Mostovich
Vladimir I Kashuba
Ingemar Ernberg
Eugene R Zabarovsky
Elvira V Grigorieva
Karolinska Institutet · SEAcademy of Medical Sciences · GBInstitute of Molecular Biology and Biophysics · RUInstitute of Molecular Biology and Genetics · UALinköping University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

microRNAs (miRNAs) are key posttranscriptional regulators of gene expression. In the present study, regulation of tumor-suppressor gene D-glucuronyl C5-epimerase (GLCE) by miRNA-218 was investigated. Significant downregulation of miRNA-218 expression was shown in primary breast tumors. Exogenous miRNA-218/anti-miRNA-218 did not affect GLCE mRNA but regulated GLCE protein level in MCF7 breast carcinoma cells in vitro. Comparative analysis showed a positive correlation between miRNA-218 and GLCE mRNA, and negative correlation between miRNA-218 and GLCE protein levels in breast tissues and primary tumors in vivo, supporting a direct involvement of miRNA-218 in posttranscriptional regulation of GLCE in human breast tissue. A common scheme for the regulation of GLCE expression in normal and tumor breast tissues is suggested.

Indexed as

Carbohydrate EpimerasesGene Expression Regulation, NeoplasticMicroRNAsBreast NeoplasmsFemaleHumansMCF-7 CellsRNA, MessengerCarbohydrate Epimerasesheparosan N-sulfate D-glucuronosyl 5-epimeraseMicroRNAsRNA, Messenger

Identifiers

PMID22968430
PMCPMC3469452
OpenAlexW2073531674

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.